Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven C Campbell

Showing results (41-50 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Urology|May 19, 2007
The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapyBrian I Rini, Steven C Campbell
Expert Review of Anticancer Therapy|December 3, 2008
Salvage of local recurrence after primary thermal ablation for small renal massesCarvell T Nguyen, Steven C Campbell
The Journal of Urology|July 21, 2009
Editorial commentSteven C Campbell, Brian R Lane
Urologic Oncology|December 14, 2011
Consolidative surgery after targeted therapy for renal cell carcinomaAnil A Thomas, Steven C Campbell
Nature Reviews. Urology|January 7, 2021
Partial nephrectomy for patients with limited life expectancy?Steven C Campbell, Rebecca A Campbell
JAMA Oncology|July 17, 2015
Urinary Biomarkers for the Detection and Management of Localized Renal Cell CarcinomaBrian I Rini, Steven C Campbell
BJU International|June 3, 2023
Zero ischaemia is not zero riskSteven C Campbell, Carlos Munoz-Lopez
The Journal of Urology|July 21, 2009
Editorial commentBrian R Lane, Steven C Campbell
The Journal of Urology|July 21, 2009
Editorial commentSteven C Campbell, Brian R Lane
Urologic Oncology|September 9, 2008
Current status of prostate-sparing cystectomyJohn C Kefer, Steven C Campbell
Pageof 31

Showing results (41-50 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Urology|May 19, 2007
The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapyBrian I Rini, Steven C Campbell
Expert Review of Anticancer Therapy|December 3, 2008
Salvage of local recurrence after primary thermal ablation for small renal massesCarvell T Nguyen, Steven C Campbell
The Journal of Urology|July 21, 2009
Editorial commentSteven C Campbell, Brian R Lane
Urologic Oncology|December 14, 2011
Consolidative surgery after targeted therapy for renal cell carcinomaAnil A Thomas, Steven C Campbell
Nature Reviews. Urology|January 7, 2021
Partial nephrectomy for patients with limited life expectancy?Steven C Campbell, Rebecca A Campbell
JAMA Oncology|July 17, 2015
Urinary Biomarkers for the Detection and Management of Localized Renal Cell CarcinomaBrian I Rini, Steven C Campbell
BJU International|June 3, 2023
Zero ischaemia is not zero riskSteven C Campbell, Carlos Munoz-Lopez
The Journal of Urology|July 21, 2009
Editorial commentBrian R Lane, Steven C Campbell
The Journal of Urology|July 21, 2009
Editorial commentSteven C Campbell, Brian R Lane
Urologic Oncology|September 9, 2008
Current status of prostate-sparing cystectomyJohn C Kefer, Steven C Campbell
Pageof 31